Antibodies that neutralize Grem1’s function in the Grem1-BMP interaction have been described, which may be beneficial not only for the treatment of pulmonary arterial hypertension [58] but also for breast cancer (by inhibiting breast cancer progression). Here, GREM1 is linked to breast cancer.